Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.
Fortin D, Cairncross GJ, Hammond RR. Fortin D, et al. Among authors: cairncross gj. Neurosurgery. 1999 Dec;45(6):1279-91; discussion 191. doi: 10.1097/00006123-199912000-00001. Neurosurgery. 1999. PMID: 10598694 Review.
Pre-radiation chemotherapy for malignant glioma in adults.
Kirby S, Macdonald D, Fisher B, Gaspar L, Cairncross G. Kirby S, et al. Can J Neurol Sci. 1996 May;23(2):123-7. doi: 10.1017/s0317167100038841. Can J Neurol Sci. 1996. PMID: 8738925
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C Jr, et al. Cairncross G, et al. J Clin Oncol. 1994 Oct;12(10):2013-21. doi: 10.1200/JCO.1994.12.10.2013. J Clin Oncol. 1994. PMID: 7931469 Clinical Trial.
Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis.
Roldán G, Scott J, George D, Parney I, Easaw J, Cairncross G, Forsyth P, Yan E. Roldán G, et al. Can J Neurol Sci. 2008 May;35(2):204-9. doi: 10.1017/s0317167100008647. Can J Neurol Sci. 2008. PMID: 18574935
Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
Cairncross G, Swinnen L, Bayer R, Rosenfeld S, Salzman D, Paleologos N, Kaminer L, Forsyth P, Stewart D, Peterson K, Hu W, Macdonald D, Ramsay D, Smith A; Oligodendroglioma Study Group. Cairncross G, et al. Neuro Oncol. 2000 Apr;2(2):114-9. doi: 10.1093/neuonc/2.2.114. Neuro Oncol. 2000. PMID: 11303620 Free PMC article.
Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma.
Cairncross G, Jenkins R. Cairncross G, et al. Cancer J. 2008 Nov-Dec;14(6):352-7. doi: 10.1097/PPO.0b013e31818d8178. Cancer J. 2008. PMID: 19060598 Review.
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
Intergroup Radiation Therapy Oncology Group Trial 9402, Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperierre N, Mehta M, Curran W. Intergroup Radiation Therapy Oncology Group Trial 9402, et al. J Clin Oncol. 2006 Jun 20;24(18):2707-14. doi: 10.1200/JCO.2005.04.3414. J Clin Oncol. 2006. PMID: 16782910 Clinical Trial.
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.
Wang M, Cairncross G, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperriere N, Mehta M, Curran W; Radiation Therapy Oncology Group (RTOG); North Central Cancer Treatment Group (NCCTG); Southwest Oncology Group (SWOG); National Cancer Institute of Canada Clinical Trials Group (NCIC CTG); Eastern Cooperative Oncology Group (ECOG). Wang M, et al. Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):662-9. doi: 10.1016/j.ijrobp.2009.06.004. Epub 2009 Sep 23. Int J Radiat Oncol Biol Phys. 2010. PMID: 19783377 Free PMC article. Clinical Trial.
12 results
Jump to page
Feedback